Downregulation of miR-34a promotes endothelial cell growth and suppresses apoptosis in atherosclerosis by regulating Bcl-2
Authors:
- 27 April 2018
- journal article
- research article
- Published by Springer Nature in Heart and Vessels
- Vol. 33 (10) , 1185-1194
Abstract
Several miRNAs have been demonstrated to be involved in endothelial dysfunction during atherosclerosis (AS). However, the detailed roles and underlying mechanisms of miR-34a in AS-associated endothelial cell apoptosis are far from being addressed. Apolipoprotein E-deficient (ApoE−/−) mice fed with high-fat diet (HFD) were used as in vivo model of AS. Oxidized low-density lipoprotein (ox-LDL)-treated human aortic endothelial cells (HAECs) were applied as in vitro model of AS. The effects of miR-34a on atherosclerotic lesions were evaluated by hematoxylin–eosin (HE) and Oil Red O staining. Pecam-1+ endothelial cells were isolated from the aortic arch with flow cytometry. qRT-PCR and western blot were employed to measure gene and protein expression. The effects of miR-34a on cell viability, cell cycle distribution, and apoptosis were assessed by Cell counting kit (CCK)-8 and flow cytometry analysis. The relationship between miR-34a and Bcl-2 was confirmed by online softwares, luciferase reporter assay, and RNA immunoprecipitation (RIP). miR-34a was upregulated in HFD-induced ApoE−/− mice and ox-LDL-treated HAECs. Anti-miR-34a decreased atherosclerotic lesions and inhibited Pecam-1+ endothelial cells apoptosis in HFD-induced ApoE−/− mice. Moreover, anti-miR-34a significantly promoted cell viability, alleviated cell cycle arrest, and restrained apoptosis in ox-LDL-treated HAECs. Furthermore, Bcl-2 was identified as a target of miR-34a, and miR-34a inhibited Bcl-2 expression via binding to its 3′UTR. Rescue experiments demonstrated that Bcl-2 overexpression dramatically reversed miR-34a-mediated inhibition of cell growth and promotion of apoptosis in ox-LDL-exposed HAECs. Depletion of miR-34a facilitated endothelial cell growth and blocked apoptosis in AS by upregulating Bcl-2, offering a promising avenue for AS therapy.Keywords
Funding Information
- Henan Provincial Department of Education research project (162102310550)
This publication has 33 references indexed in Scilit:
- MicroRNAs in the Pathobiology and Therapy of AtherosclerosisCanadian Journal of Cardiology, 2017
- Functional regulatory roles of microRNAs in atherosclerosisClinica Chimica Acta, 2016
- MicroRNA Regulation of AtherosclerosisCirculation Research, 2016
- MicroRNA-34a Plays a Key Role in Cardiac Repair and Regeneration Following Myocardial InfarctionCirculation Research, 2015
- Silencing of miR-34a Attenuates Cardiac Dysfunction in a Setting of Moderate, but Not Severe, Hypertrophic CardiomyopathyPLOS ONE, 2014
- Dietary rice protein isolate attenuates atherosclerosis in apoE-deficient mice by upregulating antioxidant enzymesAtherosclerosis, 2010
- MicroRNA-34a regulation of endothelial senescenceBiochemical and Biophysical Research Communications, 2010
- MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1American Journal of Physiology-Endocrinology and Metabolism, 2010
- Brief Report: Increased Apoptosis in Advanced Atherosclerotic Lesions of Apoe −/− Mice Lacking Macrophage Bcl-2Arteriosclerosis, Thrombosis, and Vascular Biology, 2009
- The impact of progenitor cells in atherosclerosisNature Clinical Practice Cardiovascular Medicine, 2006